Editas Medicine, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2014 | 89.5% | 89.5% | — |
| FY2015 | 87.7% | 87.7% | -48.8% |
| FY2016 | -72.2% | -72.2% | -42.4% |
| FY2017 | -57.8% | -57.8% | -32.2% |
| FY2018 | -46.6% | -46.6% | -26.2% |
| FY2019 | -51.0% | -51.0% | -26.3% |
| FY2020 | -29.5% | -29.5% | -20.3% |
| FY2021 | -34.8% | -34.8% | -28.4% |
| FY2022 | -61.1% | -61.1% | -42.9% |
| FY2023 | -43.9% | -43.9% | -30.7% |
| FY2024 | -176.6% | -127.0% | -69.4% |
| FY2025 | -586.6% | -197.9% | -85.8% |